A new re-entrant ionization chamber for the calibration of iridium-192 high dose rate sources.

Int J Radiat Oncol Biol Phys

UCLA Medical Center, Department of Radiation Oncology 90024-6951.

Published: September 1992

A re-entrant (well-type) ionization chamber has been designed and fabricated at the University of Wisconsin for use with iridium-192 high dose-rate (HDR) remote after-loading brachytherapy devices. The chamber was designed to provide an ionization current of about 10(-8) ampere with a nominal 10 curie iridium-192 source. A narrow opening is provided into the sensitive volume of the chamber to insert a Nucletron MicroSelectron catheter, or catheters with similar diameters from other HDR manufacturers. The chamber exhibits a flat response (+/- 0.1%) for any source position within +/-4 mm of the chamber center. A 300 volt chamber bias yields a 99.96% ion collection efficiency. The chamber is capable of being calibrated directly with an iridium-192 source which has in turn been calibrated with thimble-type ion chambers. Reproducibility for readings in the current mode for 10 consecutive insertions of the MicroSelectron iridium-192 HDR source is within 0.02% or less. Two thimble chambers calibrated by the U.S. National Institute of Standards and Technology provide calibration traceability of iridium-192 HDR sources and re-entrant chambers to a primary national standards laboratory. Results of activity measurements of 6 commercial iridium-192 HDR sources are reported.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0360-3016(92)91037-nDOI Listing

Publication Analysis

Top Keywords

iridium-192 hdr
12
chamber
8
ionization chamber
8
iridium-192 high
8
sources re-entrant
8
chamber designed
8
iridium-192 source
8
hdr sources
8
iridium-192
7
hdr
5

Similar Publications

Background: High-dose-rate (HDR) brachytherapy using Iridium-192 as a radiation source is widely employed in cancer treatment to deliver concentrated radiation doses while minimizing normal tissue exposure. In this treatment, the precision with which the sealed radioisotope source is delivered significantly impacts clinical outcomes.

Purpose: This study aims to evaluate the feasibility of a new four-dimensional (4D) in vivo source tracking and treatment verification system for HDR brachytherapy using a patient-specific approach.

View Article and Find Full Text PDF

Purpose: The aim of this study was a retrospective dosimetric comparison of iridium-192 (Ir) high-dose-rate (HDR) interstitial brachytherapy plans using model-based dose calculation algorithm (MBDCA) following TG-186 recommendations and TG-43 dosimetry protocol for breast, head-and-neck, and lung patient cohorts, with various treatment concepts and prescriptions.

Material And Methods: In this study, 59 interstitial Ir HDR brachytherapy cases treated in our center (22 breast, 22 head and neck, and 15 lung) were retrospectively selected and re-calculated with TG-43 dosimetry protocol as well as with Acuros BV dose calculation algorithm, with dose to medium option based on computed tomography images. Treatment planning dose volume parameter differences were determined and their significance was assessed.

View Article and Find Full Text PDF

Purpose: The present study evaluated the dosimetric impact and compared the dose variations between the advanced collapsed cone engine (Task Group 186) and Task Group 43 plans for cervical cancer using tandem and ovoid applicators.

Material And Methods: Thirty cervical cancer patients underwent iridium-192 (Ir) high-dose-rate (HDR) intra-cavitary brachytherapy using tandem and ovoid applicator. Original treatment plans for all patients were created using TG-43 dose calculation formalism.

View Article and Find Full Text PDF

Purpose: For cervical cancer patients, intra-cavitary brachytherapy (ICBT) is utilized with various dose-rate systems, such as low-dose-rate (LDR), high-dose-rate (HDR), and pulsed-dose-rate (PDR). This retrospective analysis aimed to compare the therapeutic outcomes of cervical cancer patients treated with either LDR-, HDR-, or PDR-ICBT.

Material And Methods: A total of 613 patients were treated with pelvic external beam radiation therapy (EBRT), followed by either LDR- (271 patients), HDR- (259 patients), or PDR- (83 patients) ICBT.

View Article and Find Full Text PDF

A case report of non-classical treatment choice for mycosis fungoides (MF) presented on the left upper eyelid and forehead. Superficial brachytherapy using 3D technique was prescribed to preserve the lens's functionality, and successfully eliminate malignant lesion. Treatment was conducted with high-dose-rate (HDR) brachytherapy using iridium-192 (Ir) source as a base and Flexitron device as an afterloader.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!